CF
REGN icon

Copperwynd Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Copperwynd Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$569K Buy
1,084
+81
+8% +$45.2K 0.14% 110
2025
Q1 		$636K Buy
1,003
+283
+39% +$195K 0.18% 106
2024
Q4 		$513K Sell
720
-78
-10% -$65.5K 0.14% 101
2024
Q3 		$839K Buy
798
+10
+1% +$11.1K 0.25% 78
2024
Q2 		$851K Buy
788
+35
+5% +$33.9K 0.28% 62
2024
Q1 		$725K Sell
753
-12
-2% -$11.4K 0.26% 76
2023
Q4 		$672K Sell
765
-27
-3% -$22.2K 0.27% 69
2023
Q3 		$652K Sell
792
-28
-3% -$22K 0.31% 58
2023
Q2 		$590K Sell
820
-2
-0.2% -$1.54K 0.27% 83
2023
Q1 		$676K Buy
822
+12
+1% +$9.05K 0.35% 62
2022
Q4 		$584K Sell
810
-14
-2% -$10.3K 0.33% 70
2022
Q3 		$568K Sell
824
-38
-4% -$23.9K 0.33% 65
2022
Q2 		$510K Sell
862
-12
-1% -$7.8K 0.3% 80
2022
Q1 		$610K Buy
874
+168
+24% +$106K 0.25% 86
2021
Q4 		$446K Buy
706
+2
+0.3% +$1.23K 0.17% 101
2021
Q3 		$426K Buy
+704
New +$437K 0.18% 104
2021
Q2 		– Sell
-920
Closed -$435K – 127
2021
Q1 		$435K Buy
920
+298
+48% +$145K 0.2% 100
2020
Q4 		$300K Buy
622
+149
+32% +$80.4K 0.14% 108
2020
Q3 		$265K Buy
473
+110
+30% +$66.7K 0.14% 105
2020
Q2 		$226K Buy
+363
New +$206K 0.13% 95

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Copperwynd Financial's REGN Position: Q2 2025 in Review

Copperwynd Financial increased its Regeneron Pharmaceuticals (REGN) stake by 8.1% in Q2 2025, buying an estimated $45.2K and bringing the position to 1,084 shares worth $569K. The position accounts for 0.14% of the portfolio, ranked #110.

Copperwynd Financial first reported a position in REGN in Q2 2020 and has held it in 20 quarters since. The position peaked at $851K in Q2 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Copperwynd Financial held 1,084 shares of Regeneron Pharmaceuticals worth $569K as of Q2 2025.
  • Copperwynd Financial bought 81 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $45.2K.
  • Regeneron Pharmaceuticals made up 0.14% of Copperwynd Financial's portfolio in Q2 2025, its #110 holding.
  • Copperwynd Financial first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • Copperwynd Financial's Regeneron Pharmaceuticals position peaked at $851K in Q2 2024.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Copperwynd Financial's 13F filing for Q2 2025, filed 24 Jul 2025.